abstract presentation at the 2017 ASCO Annual Meeting (June 2–6, 2017) and the full manuscript publication (March 29, 2018). The gray zones indicate the interval from the first US patient diagnosed with COVID-19 to the first stay-at-home order (California
Search Results
Fang-Shu Ou, Daniel J. Walden, Joseph J. Larson, Sandra Kang, Cassia R. Griswold, Benjamin E. Ueberroth, Bhamini Patel, Amber Draper, Puneet Raman, Olatunji B. Alese, Mohamad B. Sonbol, Tanios S. Bekaii-Saab, Christina S. Wu, and Daniel H. Ahn
Lynn A. McCain, Kara J. Milliron, Amanda M. Cook, Robert Paquette, Jasmine B. Parvaz, Susan D. Ernst, Anne L. Kittendorf, Diane M. Harper, Philip Zazove, Jim Arthurs, Jerry A. Tippie, Bailey Hulswit, Lee F. Schroeder, David F. Keren, and Sofia D. Merajver
-point scale). (C) Understandability (scores of ≥3 on a 5-point scale). Note: 2019 Q4 and 2020 Q1 are omitted due to restructuring of clinics during the COVID-19 pandemic. Abbreviations: GC, genetics clinic; PCC, primary care clinic; Q, quarter
Presented by: Lucy R. Langer, Amye J. Tevaarwerk, and Robin Zon
Moderated by: Travis Osterman
The Clinician Perspective Telemedicine refers to a remote clinical service between a patient and healthcare professional. Although it may seem that telemedicine was not widely used until the onset of the COVID-19 pandemic, the concept is
Narek Shaverdian, Erin F. Gillespie, Elaine Cha, Soo Young Kim, Stephanie Benvengo, Fumiko Chino, Jung Julie Kang, Yuelin Li, Thomas M. Atkinson, Nancy Lee, Charles M. Washington, Oren Cahlon, and Daniel R. Gomez
Background The coronavirus disease 2019 (COVID-19) pandemic has transformed cancer care in the United States with the rapid expansion of telemedicine into routine patient evaluation and management. 1 Patients with cancer are vulnerable to
Ashwin Rao, Nicole E. Rich, Jorge A. Marrero, Adam C. Yopp, and Amit G. Singal
, determinants, and impact of delays in HCC care is timely in light of the ongoing COVID-19 pandemic and its impact on healthcare delivery. In a recent American Cancer Society survey, 50% of patients with cancer reported disrupted access to healthcare, including
Alexa Wilden, Aishwarya Sannareddy, Hetal Patel, Shraddha Kansagra, Gurbakhash Kaur, Praveen Ramakrishnan, Prapti Patel, Ansh Mehta, and Ankit Kansagra
two monoclonal antibodies (MAbs), casirivimab/imdevimab and bamlanivimab, for treating mild/moderate COVID-19. In this real-world retrospective study, we aim to evaluate the efficacy of monoclonal antibody therapy in patients with and without a history
Rihab Melliti, R. Melliti, S. Tbessi, A. Chamsi, H. Ouaz, F. Bouguerra, S. Belajouza, N. Bouzid, and S. Tebra
INTRODUCTION : Coronavirus vaccination is strongly recommended for cancer patients. However, there is a limited data regarding cancer patients’ attitudes towards COVID -19 vaccination. We aim to evaluate cancer patients’ willingness to take
Nayha Tahir, Grace Ying, Sonika Prasad, and Aatma Ram
have an active mammogram order in their chart given they were either due for an annual exam or declined new order. The remaining 57 patients did not complete their mammogram for various reasons. These included but not limited to COVID-19 pandemic
Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community NCCN recognizes the rapidly changing medical information relating to COVID-19 in the oncology ecosystem, but understands that a forum for sharing best practices and specific
many personal stories our staff submitted for inclusion in our World Cancer Day challenge.” Over the past 12 months, NCCN has also worked to maintain and optimize quality cancer care during the ongoing COVID-19 pandemic. This work includes guidance
